Osler, Hoskin & Harcourt acted as Canadian counsel to Milestone Pharmaceuticals Inc. in the offering, Cooleyacted as US counsel to the company. Wilmer Cutler Pickering Hale...
Milestone Pharmaceuticals’ $34.5 Million Common Shares Offering
Linden Capital Partners’ Acquisition of Alcresta Therapeutics
Kirkland & Ellis represented Linden Capital Partners, Wilmer Cutler Pickering Hale and Dorr represented Alcresta Therapeutics and Wilson Sonsini Goodrich & Rosati advised HealthQuest Capital. Linden...
TechTarget’s Combination with Informa
Wilmer Cutler Pickering Hale and Dorr represented TechTarget, Inc. in the transaction, and Clifford Chance represented Informa PLC. TechTarget, Inc. (NASDAQ: TTGT) and Informa PLC (LSE:...